
<DOC>
<DOCNO>
WSJ900502-0031
</DOCNO>
<DOCID>
900502-0031.
</DOCID>
<HL>
   Technology:
   Cambridge BioScience Corp.
</HL>
<DATE>
05/02/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE B6
</SO>
<CO>
   CBCX
</CO>
<IN>
MEDICAL SUPPLIES (MDS)
</IN>
<GV>
FOOD AND DRUG ADMINISTRATION (FDA)
</GV>
<LP>
   WORCESTER, Mass. -- Cambridge BioScience Corp. said that
the Food and Drug Administration gave it a license for its
Recombigen AIDS antibody detection test.
   Cambridge BioScience said the two-hour test, designed for
high-volume screening at blood banks and laboratories, gives
few false positive readings compared with other tests.
</LP>
<TEXT>
</TEXT>
</DOC>